Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Absorption of AquaCelle Omega-3 Formulations in Healthy Volunteers
NCT05491759Phase 4Completed
- Sponsor
- RDC Clinical
- Start
- Aug 2022
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 4, randomised trial (3 arms), sponsored by RDC Clinical. Primary endpoint: Plasma EPA+DHA Area Under the Curve 0-24h. Started Aug 2022; status: completed.
Beyond the preview
Go deeper on NCT05491759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05491759.